Sanara MedTech
Tyler Palmer currently serves as the Chief Corporate Development & Strategy Officer at Sanara MedTech since April 2024. Previously, Tyler held the position of Senior Vice President, Corporate Development, Strategy & Product Solutions at Aquity Solutions from January 2022 until October 2023, where the company was acquired by IKS Health. Prior experience includes roles at Essity as Vice President Marketing & Business Development for Health & Medical Solutions, leading a significant integration effort from 2019 to 2022, and as Vice President at BSN medical, focusing on Consumer Health & Lymphology. Additional roles include Manager of Strategic Planning & Business Development at Zimmer Biomet and Private Equity Associate at Water Street Healthcare Partners. Tyler earned an MBA from Northwestern University - Kellogg School of Management and a Bachelor of Science in Finance from Indiana University - Kelley School of Business.
This person is not in any offices
Sanara MedTech
With our focus on improving patient outcomes with evidence-based healing solutions, Sanara MedTech Inc. develops, markets and distributes surgical, wound care and skin care products to physicians, hospitals, clinics and all post-acute care settings. We are constantly seeking long-term strategic partnerships with a focus on products that produce efficacious outcomes at a lower overall cost. Our primary products are sold in the North American advanced wound care and surgical tissue repair markets. Sanara MedTech sells and distributes CellerateRX® Surgical Activated Collagen® Powder to the surgical market and BIAKŌS™ Antimicrobial Skin and Wound Cleanser, Irrigation Solution, and Wound Gel, HYCOL® Hydrolyzed Collagen, and PULSAR II™ Advanced Wound Irrigation System (AWI™) to the wound care market.